Content provided in partnership with
Business Services Industry
Medtech Insight and Windhover Information's "In3 Medical Device Summit" Investment and Partnering Conference to Feature Presentations by 60+ Early- to Late-Stage Medical Technology Companies Seeking Funding and/or Strategic Partnership
Business Wire, May 5, 2008
June 17-19, 2008, The Palace Hotel, San Francisco, CA
NEWPORT BEACH, Calif. -- Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, has announced that it is hosting its largest strategic partnership and investment event for medical technology executives, the "Investment In Innovation (In3) Medical Device Summit," June 17-19, 2008 at The Palace Hotel in San Francisco, California. The In3 Summit is the most important venue of its kind for previewing cutting-edge emerging medical technology companies and engaging with the biggest dealmakers in the industry, including senior executives from the device industry and healthcare investment community, all in a short amount of time.
- Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »
Conference highlights will include presentations by more than 60 early- to late-stage medical technology companies, focused into 3 concurrent tracks, each followed by break-out sessions in private conference rooms. The 3 tracks will consist of 1) Cardiovascular and peripheral vascular companies, 2) Orthopedics and spine companies, and 3) Other high-growth technology areas such as device coatings/infection control, diabetes management, diagnostics, endoscopic technology, incontinence products, oncology diagnostics and therapeutics, ophthalmic surgery, and reproduction management, among others.
More than 30 presenters are confirmed to date, with many more being added to the program regularly. Track 1 (Cardio/Peripheral Vascular) presenters to date include Arterial Remodeling Technologies, CardiAQ Valve Technologies, ES Vascular Ltd., Genesis Medical Interventional, Neochord, Inc., PreMD Inc., PROTOMED, Tayside Flow Technologies Limited, Thornhill Research Inc., and Tissue Genetics. Track 2 (Ortho/Spine) presenters confirmed to date include Bone Biologics, Inc., Innova Orthopaedics, Ortho Kinematics, Orthovita, Inc., and Vertebration, Inc. Track 3 (Other High-Growth Technologies) presenting companies to date include Altascience, Ceragenix Pharmaceuticals, CVAC Systems, Inc., EyeGate Pharmaceuticals, Inc., Gel Delivery Solutions BV, Healionics Corporation, Keraderm LLC, MicroPhage, Inc., Nanobiotix, Novian Health Inc., Photo Dynamic Therapy, Polymedix, Softscope Medical Technologies, Vasorum Ltd., Vironova AB, and Zassi Medical Evolutions Inc. Visit the In3 Summit website at www.meddevicesummit.com for the latest event updates.
The Summit will kick off with a Pre-Conference Workshop hosted by Chris Velis, Chairman and CEO of Medical Capital Advisors, entitled "Top 10 Tips for Planning your VC Funding and Exit," followed by an insightful State of the Device Industry Address by David Cassak, titled "A Market Analysis of Where Medical Technology Companies are Going." Also on the program on June 18th is an informative and interactive Panel Discussion entitled "How Large Companies Sustain Growth through M&A and Strategic Partnerships," with panelists to include Richard Dakers, VP, Franchise Development, Cordis, a Johnson & Johnson Company; Stanton Rowe, Corporate VP for Advanced Technologies, Edwards Lifesciences; and Matthew Jennings, Senior Vice President, Corporate Development, Teleflex.
A Venture Capital Perspective Panel Discussion is also featured on the program on the first full day of the meeting, entitled "Early Stage Investing, Financing and Exit Strategies," that will be moderated by Steve Levin, Executive Editor at Windhover Information, with panelists to include Trevor J. Moody, Partner, Frazier Healthcare Ventures; John Maroney, General Partner, Delphi Ventures; Luke Evnin, General Partner, MPM Capital; and John Lonergan, Partner, Mach Ventures, LP. The first day is concluded with a Presenting Company Product Exhibition/Networking Reception.
On Thursday morning the 19th, a highly anticipated Emerging Markets for Medical Devices Panel Discussion will take place, titled "Mining China for Potential Investments," with panelists to include Immanuel Thangaraj, Managing Director, Essex Woodland Health Ventures; Dr. Nancy Chang, Managing Director, OrbiMed; and Carin Fradin, Executive Director, Global Healthcare Group, UBS. The exceptional In3 Summit program will also feature two educational Workshops for start-up companies, one entitled "Creating Effective Presentations: Tips for Developing, Honing and Enhancing Your Presentation Skills and Content Development," hosted by Standing Stone Partners, and the other titled "The Impact of Recent Patent Infringement Decisions and Litigation Outcomes on Your Medical Device Company," hosted by Knobbe Martens Olsen & Bear LLP.
In3 Summit co-sponsors include the AdvaMed Emerging Growth Company Council (EGCC), Battelle, Business Wire, Knobbe Martens Olson & Bear LLP, MDMA, Medmarc and The Hartford, Medical Capital Advisors, The MedTech Group, Ronald Trahan Associates, Summit Corporate Services, and F-D-C Reports' The Gray Sheet.
Find Research Guides for:
Find Featured Titles for: Arts
Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »